Literature DB >> 3754354

Homozygous protein C deficiency with moderately severe clinical symptoms.

C Sharon, M C Tirindelli, P M Mannucci, A Tripodi, G Mariani.   

Abstract

We report a large family with two members homozygotes for protein C deficiency, with activity levels of 5% and 9%. Thirteen additional members were heterozygotes, with protein C activity ranging from 36-66% and equally low levels of protein C antigen. The homozygotes presented with recurrent deep-vein thromboses and pulmonary emboli, but have reached the ages of 26 and 37 years. Hence, protein C levels of 5% appear sufficient to avoid life-threatening clinical symptoms in the neonatal period.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3754354     DOI: 10.1016/0049-3848(86)91693-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  Arterial thrombosis as clinical manifestation of congenital protein C deficiency.

Authors:  V De Stefano; G Leone; P Micalizzi; L Teofili; P G Falappa; G Pollari; B Bizzi
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

2.  Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy.

Authors:  S R Cai; S C Kennedy; W M Bowling; M W Flye; K P Ponder
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

3.  Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications.

Authors:  Paul N Knoebl
Journal:  Biologics       Date:  2008-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.